Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Brain Neoplasms × Letrozole × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Polycystic Ovary Syndrome 7 Advanced Breast Cancer 4 Recurrence 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Infertility 2 Breast Diseases 2 is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Solid Tumor 1 Pathologic Processes 1 Obesity 1 Neoplasms 1 Infertility, Female 1 Hypoxia 1 Hydatidiform Mole 1 HER2+ Breast Cancer 1 Gestational Trophoblastic Disease 1 Estrogen Receptor-positive Breast Cancer 1 Endometrioid Endometrial Cancer 1 Endometrial Neoplasms 1 ER Positive, HER2 Negative Breast Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Organoids 1 Brain Neoplasms 1 Anovulation 1

Interventions

Radiosurgery 11 Temozolomide 10 Radiotherapy 10 Magnetic Resonance Spectroscopy 7 Erlotinib Hydrochloride 6 Surgical Procedures, Operative 5 Pemetrexed 5 Gefitinib 5 Drug Therapy 5 Carboplatin 5 Bevacizumab 5 pyrotinib 4 icotinib 4 aumolertinib 4 Trastuzumab 3 Spermine Synthase 3 Radiation 3 Lomustine 3 Etoposide 3 Dexmedetomidine 3 Chlorotoxin 3 Carmustine 3 osimertinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thiotepa 2 Surveys and Questionnaires 2 Sevoflurane 2 Propofol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03122197 2023-12-13

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡